Position in SCLX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$144,159
+$24,354 QoQ
Shares Held
18,482
+2.7% QoQ
Ownership
0.218%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 23 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ashton Thomas Private Wealth, LLC holds $137,195,168 across 14 Drug Manufacturers - General names. SCLX ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
103,640 | $37,530,116 | |
| 2 | LLY |
ELI LILLY & Co
|
21,219 | $25,450,707 | |
| 3 | ABBV |
AbbVie Inc.
|
72,676 | $18,288,188 | |
| 4 | MRK |
Merck & Co., Inc.
|
120,301 | $15,458,678 | |
| 5 | JNJ |
Johnson & Johnson
|
56,610 | $14,377,241 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
62,087 | $7,844,071 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
122,267 | $7,045,024 | |
| 8 | GSK |
GSK plc
|
79,687 | $4,177,192 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,159 | 18,482 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $119,805 | 17,989 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $219,465 | 17,989 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $354,022 | 17,989 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||